Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Comparative Efficacy of Ceritinib and Crizotinib as Initial ALK –Targeted Therapies in Previously Treated Advanced NSCLC: An Adjusted Comparison with External Controls

PaperCitations, authors & open-access status

Comparative Efficacy of Ceritinib and Crizotinib as Initial ALK –Targeted Therapies in Previously Treated Advanced NSCLC: An Adjusted Comparison with External Controls is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 48 citations, 2016 year and bronze oa status.

48
Citations
2016
Year
bronze
OA Status

Related on ScholarIQ

Zheng‐Yi Zhou
Author
Journal of Thoracic Oncology
Journal
Lung Cancer Treatments and Mutations
Topic
Lung Cancer Treatments and Mutations
Topic
Lymphoma Diagnosis and Treatment
Topic
Lung Cancer Diagnosis and Treatment
Topic
470M+ articles · free account